Pacira BioSciences, Inc. — Director's Dealing 2013

Apr 29, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pacira Pharmaceuticals, Inc. (PCRX)
CIK: 0001396814
Period of Report: 2013-04-23

Reporting Person: EVNIN LUKE (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-04-23	Common Stock	S	108115	$30.00	Disposed	1169789	Indirect
2013-04-24	Common Stock	S	6303	$30.04	Disposed	1163486	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	22746	Direct

Footnotes

F1: This transaction was pursuant to a 10b5-1 Plan.

F2: The shares were sold as follows: 101,325 by MPM BioVentures IV-QP, L.P. ("BV IV QP"), 3,903 by MPM BioVentures IV GmbH & Co. Beteiligungs KG ("BV IV KG") and 2,887 by MPM Asset Management Investors BV4 LLC ("AM BV4"). MPM BioVentures IV GP LLC and MPM BioVentures IV LLC ("BV LLC") are the direct and indirect general partners of BV IV QP and BV IV KG and BV LLC is the manager of AM BV4. The Reporting Person is a member of BV LLC.

F3: The shares are held as follows: 1,096,401 by BV IV QP, 42,243 by BV IV KG and 31,145 by AM BV4. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.

F4: The shares were sold as follows: 5,907 by BV IV QP, 228 by BV IV KG and 168 by AM BV4.

F5: The shares are held as follows: 1,090,494 by BV IV QP, 42,015 by BV IV KG and 30,977 by AM BV4. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.